NIH-funded research NIH-funded research

Understanding how a bacterial toxin damages lung cells during pneumonia

Official title: Mechanism of Toxin Mediated Damage to the Lung Epithelium during S. pneumoniae Infection

Funded at San Jose State University · NIH-11061893 · Data updated 2026-11-12

This study is looking at how a toxin from a bacteria called Streptococcus pneumoniae affects lung cells, with the hope of learning more about how pneumonia damages the lungs and finding better ways to treat it.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSan Jose State University
NIH-funded
Lab location1 site (San Jose, United States)
Project startApril 1, 2024
Project endMarch 31, 2028
Funding year2025
Award (this year)$146,500
NIH project number5R16AI182337-02
Project IDNIH-11061893 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are at risk of or currently suffering from pneumonia caused by Streptococcus pneumoniae.

Less likely to help

Patients with pneumonia caused by other pathogens or those without lung epithelial damage may not benefit from this research.

What this research studies

This research investigates the effects of a toxin produced by Streptococcus pneumoniae on lung epithelial cells. It focuses on how this toxin, pneumolysin, disrupts important cell junctions that maintain the integrity of lung tissue. Using a specialized culture system that mimics lung conditions, researchers will measure changes in cell behavior when exposed to the toxin. The goal is to better understand the mechanisms of lung damage during pneumonia, which could lead to improved treatments.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that protect lung cells from damage during pneumonia infections.

How similar studies have gone: Previous research has shown that understanding bacterial toxins can lead to significant advancements in treating infections, suggesting this approach has potential for success.

Where this research is happening

  • San Jose State University
    San Jose, United States
    Active

Researchers

  • Principal investigator: Adams, Walter Isaiah — San Jose State University
  • Study coordinator: Adams, Walter Isaiah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.